1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers (IDDRCs)" is currently closed and not accepting applications.
Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers (IDDRCs) is sponsored by National Institutes of Health (NIH). This NOFO is a limited competition inviting applications for research center grants designed to advance the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities (IDD).
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
NOT-HD-24-031: Notice of Clarification Regarding the Intellectual and Developmental Disabilities Research Centers (P50 Clinical Trial Optional) Notice of Clarification Regarding the Intellectual and Developmental Disabilities Research Centers (P50 Clinical Trial Optional) June 10, 2024 - Notice of Intent to Publish a Funding Opportunity Announcement for Intellectual and Developmental Disabilities Research Centers 2025 (P50 Clinical Trial Optional) See Notice NOT-HD-24-023 April 3, 2020 - Intellectual and Developmental Disabilities Research Centers 2021 (P50 Clinical Trial Optional).
See NOFO RFA-HD-21-009. November 3, 2019 - Intellectual and Developmental Disabilities Research Centers 2020 (P50 Clinical Trial Optional). See NOFO RFA-HD-20-016 .
Eunice Kennedy Shriver National Institute of Child Health and Human Development ( NICHD ) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) intends to reissue a Notice of Funding Opportunity (NOFO) to solicit applications for research to advance the diagnosis, prevention, treatment, and amelioration of intellectual and developmental disabilities (IDD) through Intellectual and Developmental Disabilities Research Centers (IDDRCs).
Each IDDRC promotes highly collaborative, basic, translational, and clinical research in IDD. It is the intent of the NICHD to support individual IDDRCs in the current P50 award format for a final cycle of competition in FY2026. The program in its current format will be redesigned to emphasize clinical trial readiness needs that will move the field of IDD research into areas of translational research.
This Notice is intended to provide key details of the intended NOFO in order to allow potential applicants to develop responsive proposals. Details of the planned FOA are provided below.
Each IDDRC application for the final round of competition is expected to include the following components referenced in NOT-HD-24-023 : Clinical Translational Core 1-2 Additional Core(s) for a total of 3-4 Cores 2-3 Specific Research Projects designed to improve the translation of existing knowledge or strategies for the prevention, treatment, and/or amelioration of IDD Outside research projects funded by federal, state, and private sources Plans for outreach, engagement and dissemination to the community Plan for Enhancing Diverse Perspectives (PEDP) In addition to the components listed above, this NOFO will have the following elements: This funding opportunity will be limited to only currently funded IDDRCs under RFA-HD-20-016 or RFA-HD-21-009 .
The duration of each proposed IDDRC is 2 years maximum. Each IDDRC will be required to have 2-3 Specific Research Projects, and 1 of these Projects is allowed to be a completion, continuation, and/or extension of a currently supported Project. The Projects do not need to be interrelated to be responsive.
The estimated date of publication of the Notice of Funding Opportunity is Fall 2024, with awards anticipated in FY2026. See Frequently Asked Questions at https://www. nichd.
nih. gov/research/supported/eksiddrc/eksiddrc_FAQs_24 for additional information. Please direct all inquiries to: Scientific/Research Contact(s) Melissa A.
Parisi, M. D. , Ph.
D. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Weekly TOC for this Announcement NIH... Turning Discovery Into Health ®
According to the current listing, eligibility includes: Limited to applicants that are recipients of IDDRC P50 awards under RFA-HD-20-016 or RFA-HD-21-009. Refer to Section III. Eligibility Information in the NOFO for additional details. Confirm the full requirements in the official notice before applying.
The published deadline was May 15, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers (IDDRCs) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article